IL-10 R beta Products

Description

Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene.  The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo.  Chimera RNAi has many advantages over the conventional siRNAs.  First, it has been demonstrated to have reliable knock-down for over 10,000 human genes.  Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence.  Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected.  Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.

Bioinformatics

Product By Gene ID	3588
Alternate Names	CDw210b antigen CDw210b CRF2-4IL-10R subunit 2 CRFB4 CRFB4human transmembrane receptor protein; cytokine receptor10CDW210B D21S58 D21S66 IBD25 IL-10 R beta IL-10 receptor subunit beta IL10R beta IL-10R2 IL-10R2IL-10R subunit beta IL10RB IL-10Rb interleukin 10 receptor, beta Interleukin-10 receptor subunit 2 interleukin-10 receptor subunit beta member 4

Research Areas for IL-10 R beta

Find related products by research area and learn more about each of the different research areas below.

Cytokine Research
Immunology
Innate Immunity